BiomX Inc. COmmon Stock
Exchange: AMEX
Symbol: PHGE
SEC CIK: 0001739174
Phone: (972) 72 394 2377
22 EINSTEIN ST., 5TH FLOOR
NESS ZIONA L3 7414003
CEO:
|
Price when page updated: 0.34 Date: 2023-12-04
Company Website:
www.biomx.com
|
_Description: BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
IPO YEAR:
2019
|
Sector:
Health Care
|
Industry:
Biotechnology: Pharmaceutical Preparations
|
ADRTSO:
|
MarketCap:
15633108.00
|
Beta:
0.732499691145883
|
52 Week High:
9.05
|
52 Week Low:
1.42
|
52 Week Change:
-0.758957654723127
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
28581229
|
Dividend Rate:
0
|
Dividend Yield:
8.72%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
N/A
|
Float:
0
|
return on Equity:
-
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
N/A
|
ttmEPS:
0
|
Revenue:
$13.246M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
11.19%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
-
|
Return on Assets:
-
|
Return on Capital:
|
Profit Margin:
-
|
Price to Sales:
8.02
|
Price To Book:
0.93
|
Short Ratio:
0.31
|
PE Ratio:
0
|
Employees:
101
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
__The following are links to various summary and news pages for
__BiomX Inc. COmmon Stock [ PHGE ].
__Note: Some Links might not have information for the company.
|
|
